Basal Cell Carcinoma: A Frequent Challenge / Bazocelularni karcinom: čest izazov

1. Netscher DT, Spira M. Basal cell carcinoma: an overview of tumor biology and treatment. Plast Reconstr Surg 2004;113:74e-94e.10.1097/01.PRS.0000113025.69154.D1Search in Google Scholar

2. Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol 2006;19:S127-47.10.1038/modpathol.3800512Search in Google Scholar

3. Bath-Hextall F, Leonardi-Bee J, Smith C, Meal A, Hubbard R. Trends in incidence of skin basal cell carcinoma: additional evidence from a UK primary care database study. Int J Cancer 2007;121(9):2105-8.10.1002/ijc.22952Search in Google Scholar

4. Giacomel J, Zalaudek I. Dermoscopy of superficial basal cell carcinoma. Dermatol Surg 2005;31(12):1710-3.Search in Google Scholar

5. Unpublished data of the Cancer Registry (Registry for malignant neoplasms) of Vojvodina. Sremska Kamenica: Oncology Institute of Vojvodina; 2011.Search in Google Scholar

6. Rubin AI, Elbert HC, Ratner D. Basal Cell Carcinoma. N Engl J Med 2005;353(21): 2262-9.10.1056/NEJMra044151Search in Google Scholar

7. Berlin JM, Warner MR, Bailin PL. Metastatic basal cell carcinoma presenting as unilateral axillary lymphadenopathy: report of a case and review of the literature. Dermatol Surg 2002;28:1082-4.10.1097/00042728-200211000-00022Search in Google Scholar

8. Wadhera A, Fazio M, Bricca G, Stanton O. Metastatic basal cell carcinoma: a case report and literature review. How accurate is our incidence data? Dermatol Online J 2006;12(5):7.Search in Google Scholar

9. Robinson JK, Dahiya M. Basal cell carcinoma with pulmonary and lymph node metastasis causing death. Arch Dermatol 2003;139:643-8.10.1001/archderm.139.5.643Search in Google Scholar

10. Popadić S, Tanasilović S, Živanović D, Medenica Lj. Genital superficial basal cell carcinoma: a case report. Serb J Dermatol Venereol 2010;2(3):106-9.10.2478/v10249-011-0027-7Search in Google Scholar

11. Lo Muzio L. Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis 2008;3:32.10.1186/1750-1172-3-32Search in Google Scholar

12. Menzies SW. Dermoscopy of pigmented basal cell carcinoma. Clin Dermatol 2002; 20(3):268-9.10.1016/S0738-081X(02)00229-8Search in Google Scholar

13. Kreusch JF. Vascular patterns in skin tumors. Clin Dermatol 2002;20(3):248-54.10.1016/S0738-081X(02)00227-4Search in Google Scholar

14. Argenziano G, Zalaudek I, Corona R, Sera F, Cicale L, Petrillo G, et al. Vascular structures in skin tumors: a dermoscopy study. Arch Dermatol 2004;140(12):1485-9.10.1001/archderm.140.12.148515611426Search in Google Scholar

15. Scalvenzi M, Lembo S, Francia MG, Balato A. Dermoscopic patterns of superficial basal cell carcinoma. Int J Dermatol 2008;47:1015-8.10.1111/j.1365-4632.2008.03731.xSearch in Google Scholar

16. Ulrich M, Astner S, Stockfleth E, Rowert-Huber J. Noninvasive diagnosis of non-melanoma skin cancer: focus on reflectance confocal microscopy. Expert Rev Dermatol 2008;3(5):557-67.10.1586/17469872.3.5.557Search in Google Scholar

17. Desai TD, Desai AD, Horowitz DC, Kartono F, Wahl T. The use of high-frequency ultrasound in the evaluation of superficial and nodular basal cell carcinoma. Dermatol Surg 2007;33:1220-7.Search in Google Scholar

18. Mogensen M, Jemec GBE. Diagnosis of nonmelanoma skin cancer/keratinocyte carcinoma: a review of diagnostic accuracy of nonmelanoma skin cancer diagnostic tests and technologies. Dermatol Surg 2007;33:1158-74.10.1097/00042728-200710000-00003Search in Google Scholar

19. Fitzpatrick JE, Whalen EA. Basal cell carcinoma or not? Histological variants and mimics of the most common cutaneous malignancy. Semin Cutan Med Surg 1999;18(1):15-24.10.1016/S1085-5629(99)80004-2Search in Google Scholar

20. Vantuchova Y, Curik R. Histological types of basal cell carcinoma. Scr Med (BRNO) 2006;79(5-6):261-70.Search in Google Scholar

21. LeBoit PE, Burg G, Weedon D, Sarasin A, eds. World Health Organisation Classification of tumors: pathology and genetics of skin tumors. Lyon: IARC Press; 2006. p. 10-33.Search in Google Scholar

22. Constantino D, Lowe L, Brown DL. Basosquamous carcinoma - an under-recognized, high risk cutaneous neoplasm: case study and review of the literature. J Plast Reconstr Aesthet Surg 2006;59:424-8.10.1016/j.bjps.2005.06.00716756261Search in Google Scholar

23. Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basosquamous carcinoma treatment with Mohs micrographic surgery. Cancer 2005;104(1):170-5.10.1002/cncr.2114315929123Search in Google Scholar

24. Hussain SI, Hussainy AS. Baso-squamous cell carcinoma: a case report. J Pak Med Assoc 2004;54(1):30-2.Search in Google Scholar

25. Cohen PR, Schulze KE, Nelson BR. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer. Dermatol Surg 2006;32:542-51.10.1097/00042728-200604000-00011Search in Google Scholar

26. Telfer NR, Colver GB, Morton CA. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008;159:35-48.10.1111/j.1365-2133.2008.08666.x18593385Search in Google Scholar

27. Ceilley RI, Del Rosso JQ. Current modalities and new advances in the treatment of basal cell carcinoma. Int J Dermatol 2006;45:489-98.10.1111/j.1365-4632.2006.02673.x16700779Search in Google Scholar

28. Semchyshyn NL, Sengelmann RD. Surgical complications. Medscape.com [homepage on the Internet]. New York: Medscape, LLC; © 1994-2012 [cited 2012 Jan 9]. Available from: http:// emedicine.medscape.com/article/1128404-overview.Search in Google Scholar

29. Steinman HK. Indications for Mohs surgery. In: Gross KG, Steinman HK, Rapini RP, eds. Mohs surgery: fundamentals and techniques. St Louis (Missouri): Mosby Inc; 1999. p. 4-14.Search in Google Scholar

30. Goncalves JC, Martins C. Debulking of skin cancers with radio frequency before cryosurgery. Dermatol Surg 1997;23(4):253-6.10.1111/j.1524-4725.1997.tb00038.x9149791Search in Google Scholar

31. Patidar S. Excision of basal cell carcinoma with radio frequency ablation. J Cutan Aesthet Surg 2008;1(1):29-30.10.4103/0974-2077.41157Search in Google Scholar

32. Barlow RJ. Lasers and flashlamps in the treatment of skin disorders. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook’s textbook of dermatology. 6th ed. Oxford: Blackwell Publishing Ltd; 2010. Chapter 78; p. 1-15.10.1002/9781444317633.ch78Search in Google Scholar

33. Sedda AF, Rossi G, Cipriani C, Carrozzo AM, Donati P. Dermatological high-dose-rate brachytherapy for the treatment of basal and squamous cell carcinoma. Clin Exp Dermatol 2008;33:745-9.10.1111/j.1365-2230.2008.02852.xSearch in Google Scholar

34. Foley P, Freeman M, Menter A, Siller G, El-Azhary RA, Gebauer K, et al. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies. Int J Dermatol 2009;48:1236-45.10.1111/j.1365-4632.2008.04022.xSearch in Google Scholar

35. Torres A, Niemeyer A, Berkes B, Marra D, Schanbacher C, Gonzales S, et al. 5% Imiquimod cream and reflectancemode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma. Dermatol Surg 2004; 30:1462-9.Search in Google Scholar

36. Meads SB, Greenway HT. Basal cell carcinoma associated with orbital invasion: clinical features and treatment options. Dermatol Surg 2006;32(3):442-6.Search in Google Scholar

37. Dirix L, Migden MR, Oro AE, Hauschild A, Lewis K, Mueller AB, et al. A pivotal multicenter trial evaluating efficacy and safety of the hedgehog pathway inhibitor (HPI) vismodegib in patients with advanced basal cell carcinoma (BCC). Eur J Cancer 2011;47(Suppl 2):2.10.1016/S0959-8049(11)70096-XSearch in Google Scholar

38. De Smaele E, Ferretti E, Gulino A. Vismodegib, a smallmolecule inhibitor of the hedgehog pathway for the treatment of advanced cancers. Curr Opin Inves Drugs 2010;11(6):707-18.Search in Google Scholar

39. Punjabi S, Cook LJ, Kersey P, Marks R, Cerio R. Solasodine glycoalkaloids: a novel topical therapy for basal cell carcinoma. A double-blind, randomized, placebo-controlled, parallel group, multicenter study. Int J Dermatol 2008;47:78-82.10.1111/j.1365-4632.2007.03363.xSearch in Google Scholar

40. Bianchi L, Orlandi A, Campione E, Angeloni C, Costanzo A, Spagnoli LG, et al. Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases. Br J Dermatol 2004;151:148-56.10.1111/j.1365-2133.2004.06044.xSearch in Google Scholar

41. El-Tonsy MH, El-Domyati MM, El-Sawy AE, El-Din WH, Anbar TEA, Raouf HA. Continuous-wave Nd:Yag laser hyperthermia: a successful modality in treatment of basal cell carcinoma. Dermatol Online J 2004;10(2):3.10.5070/D38ZC331CTSearch in Google Scholar

42. Rodriguez-Cuevas S, Barroso-Bravo S, Almanza-Estrada J, Cristobal- Martinez L, Gonzales-Rodrigues E. Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin. Arch Med Res 2001;32:273-6.10.1016/S0188-4409(01)00278-8Search in Google Scholar

43. Harris RB, Alberts DS. Strategies for skin cancer prevention. Int J Dermatol 2004;43:243-51.10.1111/j.1365-4632.2004.01966.x15090005Search in Google Scholar

44. Prado R, Francis SO, Mason MN, Wing G, Gamble RG, Dellavalle R. Nonmelanoma skin cancer chemoprevention. Dermatol Surg 2011;37(11):1566-78.10.1111/j.1524-4725.2011.02108.x21895847Search in Google Scholar

45. Otley CC, Stasko T, Tope WD, Phil M, Lebwohl M. Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects. Dermatol Surg 2006;32:562-8.10.1097/00042728-200604000-00015Search in Google Scholar

46. Van Iersel CA, Van de Velden HVN, Kusters CDJ, Spauwen PHM, Blokx WAM, Kiemeney LALM, et al. Prognostic factors for a subsequent basal cell carcinoma: implications for followup. Br J Dermatol 2005;153:1078-80.10.1111/j.1365-2133.2005.06911.x16225637Search in Google Scholar

47. McLoone NM, Tolland J, Walsh M, Dolan OM. Follow-up of basal cell carcinomas: an audit of current practice. J Eur Acad Dermatol Venereol 2006;20:698-701. 10.1111/j.1468-3083.2006.01576.x16836498Search in Google Scholar